| |
CKD 1–2
|
CKD 3–4
|
ESRD
|
|---|
|
n = 21
|
n = 67
|
n = 24
|
|---|
|
Sex
|
Male
|
12 (17.6%)
|
42 (61.8%)
|
14 (20.6%)
|
|
Female
|
9 (20.5%)
|
25 (56.8%)
|
10 (22.7%)
|
|
Age (years)
| |
52 (42–62)
|
62 (56–73)
|
56.5 (47–63.8)
|
|
Duration after nephrectomy (years)
| |
4 (2.5–10.5)
|
5 (1–12)
|
12 (5–19.5)
|
|
Serum creatinine (μmol/L)
| |
81 (68.5–99)
|
127 (112–150.3)
|
658.5 (475.3–996.2)
|
|
eGFR (ml/min/1.73 m2)
| |
85.5 ± 14.9
|
46.7 ± 9.2
|
6.3 ± 2.5
|
|
Proteinuria
|
No
|
12 (23.1%)
|
37 (71.2%)
|
3 (5.7%)
|
|
Yes
|
9 (20%)
|
24 (53.3%)
|
12 (26.7%)
|
|
Hematuria
|
No
|
8 (10.1%)
|
53 (67.1%)
|
18 (22.8%)
|
|
Yes
|
13 (39.4%)
|
14 (42.4%)
|
6 (18.2%)
|
|
Kidney location
|
Left
|
8 (14.0%)
|
37 (64.9%)
|
12 (21.1%)
|
|
Right
|
13 (23.6%)
|
31 (56.4%)
|
11 (20%)
|
|
Cause of ASK
|
Tumors
|
11 (30.6%)
|
22 (61.1%)
|
3 (8.3%)
|
|
Tuberculosis
|
6 (13%)
|
29 (63%)
|
11 (23.9%)
|
|
Trauma
|
1 (25%)
|
1 (25%)
|
2 (50%)
|
|
Other
|
1 (9.1%)
|
5 (45.5%)
|
5 (45.5%)
|
|
Unknown
|
2 (13.3%)
|
10 (66.7%)
|
3 (20%)
|
|
Current smoker
|
No
|
17 (19.8%)
|
50 (58.1%)
|
19 (22.1%)
|
|
Yes
|
4 (15.4%)
|
17 (65.4%)
|
5 (19.2%)
|
|
History of CVD
|
No
|
18 (23.1%)
|
46 (59%)
|
14 (17.9%)
|
|
Yes
|
3 (8.8%)
|
21 (61.8%)
|
10 (29.4%)
|
|
Hypertension
|
No
|
9 (19.1%)
|
30 (63.8%)
|
8 (17%)
|
|
Yes
|
11 (18%)
|
35 (57.4%)
|
15 (24.6%)
|
|
Obesity
|
No
|
12 (18.5%)
|
36 (55.4%)
|
22 (26.2%)
|
|
Yes
|
5 (14.3%)
|
24 (68.6%)
|
6 (17.1%)
|
|
Diabetes
|
No
|
20 (28.6%)
|
35 (50%)
|
15 (21.4%)
|
|
Yes
|
1 (2.8%)
|
28 (77.8%)
|
7 (19.4%)
|
|
Hyperuricemia
|
No
|
16 (25%)
|
38 (59.4%)
|
10 (15.6%)
|
|
Yes
|
4 (8.9%)
|
27 (60%)
|
14 (31.1%)
|
|
Dyslipidemia
|
No
|
14 (15.1%)
|
58 (62.4%)
|
21 (22.5%)
|
|
Yes
|
2 (18.2%)
|
9 (81.8%)
|
0 (0%)
|
- Note: Results are presented as numbers (percentages), medians (interquartile range), or medians (standard deviation); eGFR estimated glomerular filtration rate, ASK acquired solitary kidney, CVD cardiovascular disease
